Co-Diagnostics joint venture publishes peer-reviewed HPV screening study using SARAGENE test

A study using CoSara's SARAGENE HPV test identified high-grade lesions or cancer in 12 of 20 HPV-positive women, most with negative cytology. The peer-reviewed publication supports the test's potential role in cervical cancer screening across India and South Asia.